CANDRIAM S.C.A. – Mersana Therapeutics, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$16.88M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+46.32%
quarter
Mersana Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +25.49% | 507.36K shares | 7.69M | $6.76 | 2.49M |
| Q2 2022 | share | Increase | +7.90% | 145.73K shares | 1.83M | $4.62 | 1.99M |
| Q1 2022 | share | Decrease | -8.80% | -178.07K shares | -5.22M | $3.99 | 1.84M |
| Q4 2021 | share | Decrease | -0.00% | -79 shares | -6.49M | $6.4 | 2.02M |
| Q3 2021 | share | Increase | +2.53% | 50K shares | -7.71M | $9.43 | 2.02M |
| Q2 2021 | share | Increase | +75.81% | 850.72K shares | -1.89M | $13.58 | 1.97M |
| Q1 2021 | share | Increase | 0.00% | 28 shares | -1.17M | $16.18 | 1.12M |
| Q4 2020 | share | Increase | +90.94% | 534.43K shares | 18.91M | $26.61 | 1.12M |
| Q3 2020 | share | Decrease | -1.35% | -8.03K shares | -2.99M | $18.62 | 587.70K |
| Q2 2020 | share | Increase | 0.00% | 595.74K shares | 13.94M | $23.4 | 595.74K |
| Q2 2018 | share | Decrease | -100.00% | -36K shares | -568K | $17.86 | 0 |
| Q1 2018 | share | Increase | +200.00% | 24K shares | 371K | $15.77 | 36K |
| Q4 2017 | share | Increase | 0.00% | 12K shares | 197K | $16.43 | 12K |